Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

Targeting THY1 can improve skin repair and healing.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Restoring hair follicle immune privilege may help treat alopecia areata.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Baricitinib is a promising treatment for alopecia areata.

CRH causes hair loss by reducing cell survival in hair follicles.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

A woman with hypothyroidism stopped taking levothyroxine after successful homeopathic treatment.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Activating Tgr5 may help treat hair loss and bone loss.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.